首页> 美国政府科技报告 >Update: Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions Recommendations to the Advisory Committee on Immunization Practices (ACIP)
【24h】

Update: Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions Recommendations to the Advisory Committee on Immunization Practices (ACIP)

机译:更新:疫苗副作用,不良反应,禁忌症和预防措施建议免疫实践咨询委员会(aCIp)

获取原文

摘要

This report provides updated information concerning the potential adverse events associated with vaccination for hepatitis B, poliomyelitis, measles, mumps, diphtheria, tetanus, and pertussis. This information incorporates findings from a series of recent literature reviews, conducted by an expert committee at the Institute of Medicine (lOM), of all evidence regarding the possible adverse consequences of vaccines administered to children. This report contains modifications to the previously published recommendations of the Advisory Committee on Immunization Practices (ACIP) and is based on an ACIP review of the lOM findings and new research on vaccine safety. In addition, this report incorporates information contained in the 'Recommendations of the Advisory Committee on Immunization Practices: Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence' (MMWR 1993 ;42 No. RR-4) and the 'General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)' (MMWR l994;43 No. RR-l). Major changes to the previous recommendations are highlighted within the text, and specific information concerning the following vaccines and the possible adverse events associated with their administration are included: hepatitis B vaccine and anaphylaxis; measles vaccine and (a) thrombocytopenia and (b) possible risk for death resulting from anaphylaxis or disseminated disease in immunocompromised persons; diphtheria and tetanus toxoids and pertussis vaccine (DTP) and chronic encephalopathy; and tetanus- toxoid-containing vaccines and (a) Guillain-Barre syndrome, (b) brachial neuritis, and (c) possible risk for death resulting from anaphylaxis. These modifications will be incorporated into more comprehensive ACIP recommendations for each vaccine when such statements are revised.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号